skip to main content
Refinado por: Base de dados/Biblioteca: ClinicalKey remover idioma: Russo remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Once-daily dolutegravir versus twice-daily raltegravir in antiretroviral-naive adults with HIV-1 infection (SPRING-2 study): 96 week results from a randomised, double-blind, non-inferiority trial
Material Type:
Artigo
Adicionar ao Meu Espaço

Once-daily dolutegravir versus twice-daily raltegravir in antiretroviral-naive adults with HIV-1 infection (SPRING-2 study): 96 week results from a randomised, double-blind, non-inferiority trial

Raffi, François, Prof ; Jaeger, Hans, MD ; Quiros-Roldan, Eugenia, MD ; Albrecht, Helmut, Prof ; Belonosova, Elena, MD ; Gatell, Jose M, Prof ; Baril, Jean-Guy, MD ; Domingo, Pere, MD ; Brennan, Clare, DPT ; Almond, Steve, MMath ; Min, Sherene, MD

The Lancet infectious diseases, 2013-11, Vol.13 (11), p.927-935 [Periódico revisado por pares]

London: Elsevier Ltd

Texto completo disponível

2
Once daily dolutegravir (S/GSK1349572) in combination therapy in antiretroviral-naive adults with HIV: planned interim 48 week results from SPRING-1, a dose-ranging, randomised, phase 2b trial
Material Type:
Artigo
Adicionar ao Meu Espaço

Once daily dolutegravir (S/GSK1349572) in combination therapy in antiretroviral-naive adults with HIV: planned interim 48 week results from SPRING-1, a dose-ranging, randomised, phase 2b trial

van Lunzen, Jan, Prof ; Maggiolo, Franco, MD ; Arribas, José R, Prof ; Rakhmanova, Aza, MD ; Yeni, Patrick, Prof ; Young, Benjamin, MD ; Rockstroh, Jürgen K, Prof ; Almond, Steve, MMath ; Song, Ivy, PhD ; Brothers, Cindy, MSPH ; Min, Sherene, MD

The Lancet infectious diseases, 2012-02, Vol.12 (2), p.111-118 [Periódico revisado por pares]

London: Elsevier Ltd

Texto completo disponível

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Data de Publicação 

De até

Buscando em bases de dados remotas. Favor aguardar.